Answers are grounded in this paper and cite their sources.
Cholangiocarcinoma (CCA) is an aggressive bile duct malignancy with limited treatment options and poor prognosis, particularly in Southeast Asia. Photodynamic therapy (PDT) offers a selective therapeutic approach, but its efficacy is restricted by tumor hypoxia, which limits oxygen‐dependent Type‐II photosensitization. Herein, a gold‐based nanoplatform was developed by loading an iodinated near‐infrared aza‐BODIPY photosensitizer ( AZB‐I ) onto γ ‐radiation‐synthesized gold nanoparticles and stabilizing the system with Pluronic F127. The resulting AZB‐I@AuNPs‐F127 nanoparticles exhibited good aqueous stability, a hydrodynamic size of approximately 238 nm, and improved delivery of AZB‐I . Under NIR LED irradiation, corrected singlet oxygen quantum yields were comparable for AZB‐I@AuNPs‐F127 and free AZB‐I (0.10 and 0.11, respectively). Mechanistic studies confirmed that AZB‐I@AuNPs‐F127 promotes both Type‐II singlet oxygen generation and Type‐I radical formation, including hydroxyl and superoxide radicals. This dual Type‐I/Type‐II mechanism enhanced PDT efficacy under hypoxia, where AZB‐I@AuNPs‐F127 showed an IC 50 of 0.39 µM, outperforming free AZB‐I (0.91 µM). In KKU‐213A xenograft mice, AZB‐I@AuNPs‐F127 with 660 nm irradiation reduced tumor volume by 60% without observable systemic toxicity, demonstrating its promise for hypoxia‐tolerant CCA PDT.
No takes yet. Share an insight, caveat, or question.
Mahingsadet et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: